Balyasny Asset Management’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-123,881
Closed -$686K 2555
2023
Q2
$686K Buy
+123,881
New +$679K ﹤0.01% 1761
2023
Q1
Sell
-490,214
Closed -$3.43M 2973
2022
Q4
$3.43M Buy
+490,214
New +$5.04M 0.01% 1191

Other funds holding MSOS

Balyasny Asset Management's MSOS Position: Q3 2023 in Review

Balyasny Asset Management sold out of AdvisorShares Pure US Cannabis ETF (MSOS) in Q3 2023, closing a stake of 123,881 shares — an estimated $686K sold.

Balyasny Asset Management first reported a position in MSOS in Q4 2022 and held it in 2 quarters. The position peaked at $3.43M in Q4 2022. 162 funds tracked by Wall St. Rank hold MSOS as of Q3 2023.

  • Balyasny Asset Management reported no remaining AdvisorShares Pure US Cannabis ETF position as of Q3 2023 after selling out during the quarter.
  • Balyasny Asset Management sold 123,881 AdvisorShares Pure US Cannabis ETF shares in Q3 2023, an estimated $686K.
  • Balyasny Asset Management first reported a position in AdvisorShares Pure US Cannabis ETF in Q4 2022 and held it in 2 quarters.
  • Balyasny Asset Management's AdvisorShares Pure US Cannabis ETF position peaked at $3.43M in Q4 2022.
  • 162 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q3 2023.

Based on Balyasny Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.